Udenyca (Biosimilar to Neulasta) Now Approved Page Nov 14, 2018Nov 13, 2018 Brand: Udenyca (pegfilgrastim-cbqv), Injection Parent Company: Coherus Drug Type: Prescription Drug Category: Oncology Campaign: now-approved Targeting: HCPs Patient Website: http://www.udenyca.com/ HCP Website: Home Home – Animation 1 Home – Animation 2 Mobile View